Cancer Genetics & Epigenetics

Cancer is fundamentally a disease of tissue growth regulation. Oncogenes and tumour suppressor genes are the two primary types of impacted genes. Oncogenes are genes that promote cell growth and replication. Tumor suppressor genes are those that prevent cell division and survival. Malignant transformation can occur as a result of the emergence of novel Oncogenes, the inappropriate over-expression of known Oncogenes, or the under-expression or inactivation of Tumour Suppressor Genes.

Cancer Epigenetics is the study of epigenetic modifications to the genome of cancer cells that do not involve any changes to the nucleotide sequence. Epigenetic changes are as important as genetic mutations in the transformation of normal cells to cancer cells, and their management holds remarkable promise for cancer prevention, detection, and treatment. In many kinds of cancer, a variety of epigenetic mechanisms can be perturbed, such as silencing of Tumour Suppressor Genes and activation of Oncogenes by altered histone modifications, CpG island methylation patterns, and dysregulation of DNA binding proteins.

Effects of epigenetics:

  • Diet
  • Obesity
  • Physical activity
  • Tobacco smoking
  • Alcohol consumption
  • Environmental pollutants
  • Psychological stress and
  • Working on night shifts


    Related Conference of Cancer Genetics & Epigenetics

    March 18-19, 2024

    5th Global Summit on Oncology and Hematology

    Zurich, Switzerland
    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France

    Cancer Genetics & Epigenetics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in